Novocure Receives FDA Approval for Second Generation Optune System
Go back to Novocure Receives FDA Approval for Second Generation Optune System| (NASDAQ: NVCR) | Delayed: 16.31 -0.72 (4.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.03 | 52 Week High | $28.95 | |||
| Open | $16.99 | 52 Week Low | $5.95 | |||
| Day High | $17.05 | P/E | N/A | |||
| Day Low | $16.16 | EPS | $0.00 | |||
| Volume | 1,383,902 | |||||
